Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: Immunohistochemical study

Journal of Comparative Neurology

Volumn 474, Issue 4, 2004, Pages 487-503

  Goncharuk, Valeri ^a,b   Zeng, Zhizhen ^c   Wang, Ruiping ^c   Mactavish, David ^b   Jhamandas, Jack H ^b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Morphine modulatory peptide; Neuropeptide FF; NPFF; NPFF1; RF amide

Indexed keywords

MORPHINE MODULATORY PEPTIDE; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE FF1 RECEPTOR; NEUROPEPTIDE FF2 RECEPTOR; NEUROPEPTIDE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR HYPOTHALAMUS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; FEMALE; FOREBRAIN; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS;

ADULT; FEMALE; HUMANS; HYPOTHALAMUS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSENCEPHALON; RECEPTORS, NEUROPEPTIDE;

EID: 2642576737     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20132     Document Type: Article

References (62)

1. Allard M, Zajac JM, Simonnet G. 1992. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 49:101-116.
2. Allard M, Labrouche S, Nosjean A, Laguzzi R. 1995. Mechanism underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J Pharmacol Exp Ther 271:577-583.
3. Arima H, Murase T, Kondo K, Iwasaki Y, Oiso Y. 1996. Centrally administred neuropeptide FF inhibits arginine vasopressin release in conscious rats. Endocrinology 137:1523-1529.
4. Bagnasco M, Tulipano G, Melis MR, Argiolas A, Cocchi D, Muller EE. 2003. Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul Pept 111:161-167.
5. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yao WJ, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B. 2000. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275: 39324-39331.
6. Chen X, Zidichouski A, Harris K, Jhamandas JH. 2000. Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors. J Neurophysiol 84:744-751.
7. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu M, Pinto S, Colmers WF, Cone RD, Horvath TL. 2003. The distribution and mechanism of action of ghrelin in the CNS demonstrated a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661.
8. Dai J, Swaab DF, Buijs RM. 1997. Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol 383:397-414.
9. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. 2000. Noradrenaline in the ventral forebrain is crucial for opiate withdrawal-induced aversion. Nature 403:430-434.
10. Desprat C, Zajac JM. 1997. Hypothermic effects neuropeptide FF analogues in mice. Pharmacol Biochem Behav 58:559-563.
11. Earle ML, Pittman QJ. 1995. Involvement of the PVN and BST in 1K1C hypertension in the rat. Brain Res 669:41-47.
12. Elias CF, Kelly JF, Ahima RS, Drucker DJ, Saper CB, Elmquist JK. 2000. Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261-281.
13. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekers PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Miligan G, Groarke DA. 2000. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275:25965-25971.
14. Engstrom MT, Brandt A, Wurster S, Savola JM, Panula P. 2003. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J Pharmacol Exp Ther 305:825-832.
15. Fujii R, Fukusumi S, Hosoya M, Kawamata Y, Habata Y, Hinuma S, Sekiguchi M, Kitada C, Kurokawa T, Nishimura O, Onda H, Sumino Y, Fujino M. 1999. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul Pept 83:1-10.
16. Fukusumi S, Habada Y, Yoshida H, Iijima N, Kawamata Y, Hosoya M, Fujii R, Hinuma S, Kitada C, Shintani Y, Suenaga M, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M. 2001. Characteristics and distribution of endogenous RFamide-related peptide-I. Biochim Biophys Acta 1540:221-232.
17. Gicquel S, Fioramonti J, Bueno L, Zajac JM. 1993. Effects of F8F amide analogs on intestinal transit in mice. Peptides 14:749-753.
18. 125]EYF as selective radioligands. Neuroscience 115:349-361.
19. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. 1998. Coexpression of Agrp and NPY in fasting activated hypothalamic neurons. Nat Neurosci 1:271-272.
20. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. 1998. A prolactin-releasing peptide in the brain. Nature 393:272-276.
21. Hinuma S, Shitani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y, Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M. 2000. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2:703-708.
22. Jhamandas JH, MacTavish D. 2003. Central administration of neuropeptide FF causes activation of oxytocin paraventricular neurons that project to the brain stem. J Neuroendocrinol 15:24-32.
23. Jhamandas JH, Raby W, Rogers J, Buijs RM, Renaud LP. 1989. Diagonal band projection toward the hypothalamic supraoptic nucleus: light and electron microscopic observations in the rat. J Comp Neurol 282:15-23.
24. Jhamandas JH, Goncharuk V, Buijs RM. 2002. Distribution of neuropeptide FF (NPFF) in the human brain: relationship to tyrosine hydtoxylase (TH) and vasopressin (VP) neurons. Program No. 827.7.2002, Abstract Viewer Itinerary Planner. Washington, DC: Society for Neuroscience.
25. Kivipelto L. 1991. Ultrastructural localization of neuropeptide FF, a new neuropeptide in the rat brain and pituitary of rats. Regul Pept 34:211-224.
26. Koutcherov Y, Mai JK, Ashwell KWS, Paxinos G. 2000. Organization of the human paraventricular hypothalamic nucleus. J Comp Neurol 423: 299-318.
27. Lawrence CB, Celsi F, Brennand J, Luckman SM. 2000. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci 3:645-649.
28. Li C, Kim K, Nelson LS. 1999. FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. Brain Res 848:26-34.
29. Liu Q, Guan XM, Martin WJ, McDonald TP, Clemens MK, Jiang Q, Zeng Z, Jacobson M, Williams DL Jr, Yu H, Bomford D, Figuroa D, Mallee J, Wang R, Evans J, Gould R, Austin CP. 2001. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276:36961-36969.
30. Mai JK, Assheuer J, Paxinos G. 1997. Atlas of the human brain. London: Academic Press.
31. Malin DH, Lake JR, Fowler DE, Hammond MV, Brown SL, Leyva JE, Prasco PE, Dougherty TM. 1990. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11:277-280.
32. Maruyama M, Matsumoto H, Fujiwara K, Kitada C, Hinuma S, Onda H, Fujino M, Inoue K. 1999a. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology 140:2326-2333.
33. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M, Higuchi T, Inoue K. 1999b. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci Lett 276:193-196.
34. Matsumoto H, Murakami Y, Horikoshi Y, Noguchi J, Habata Y, Kitada C, Hinuma S, Onda H, Fujino M. 1999. Distribution and characterization of immunoreactive prolactin-releasing peptide (PrRP) in rat tissue and plasma. Biochem Biophys Res Commun 257:264-268.
35. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, Hinuma S, Onda H, Nishimura O, Inoue K, Fujino M. 2000. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett 285:234-238.
36. Menninken F, Hoffert C, Neale C, Ahmad S, O'Donnell D. 2002. Differential distribution of neuropeptide FF receptors, NPFF1 and NPFF2, in the adult rat CNS. Program No. 849.19.2002, Abstract Viewer/Itineary Planner. Washington, DC: Society for Neuroscience.
37. Merte J, Nichols R. 2002. Drosophila melanogaster FMRFamide-containing peptides: redundant or diverse functions? Peptides 23:209-220.
38. Mignot E. 2001. A commentary on the neurobiology of the hypocretin/ orexin system. Neuropsychopharmacology 25(Suppl 5):S5-S13.
39. Minault M, Lecron JC, Labrouche S, Simonnet G, Gombert J. 1995. Characterization of binding sites for neuropeptide FF on lymphocytes of the Jurkat cell line. Peptides 16:105-111.
40. Mukherjee K, Mathur R, Nayar U. 2001. Ventromedial hypothalamic mediation of sucrose feeding induced pain modulation. Pharmacol Biochem Behav 68:43-48.
41. Mungarndee SS, Baldwin BA, Chindadoungratana C, Kotchabhakdi N. 2002. Hypothalamic and zona incerta neurons in sheep, initially only responding to the sight of food, also respond to the sight of water after intracerebroventricular injection of hypertonic saline or angiotensin II. Brain Res 925:204-212.
42. Murase T, Arima H, Kondo K, Oiso Y. 1996. Neuropeptide FF reduces food intake in rats. Peptides 17:353-354.
43. Panula P, Aarnisalo AA, Wasowich K. 1996. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48:461-487.
44. Panula P, Kalso E, Nieminen ML, Kontinen VK, Brandt A, Pertovaara A. 1999. Neuropeptide FF and modulation of pain. Brain Res 848:191-196.
45. Perry SJ, Huang EY, Cronk D, Bagust J, Sharma R, Walker RJ, Wilson S, Burke JF. 1997. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409:426-430.
46. Roth BL, Disimone J, Majane EA, Yang HY. 1987. Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum. Neuropeptides 10:37-42.
47. Sakamoto N, Pearson J, Shinoda K, Alheid GF, De Olmos JS, Heimer L. 1999. The human basal forebrain. Part 1. An overview. In: Bloom FE, Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy, vol 15: the primate nervous system, part 3. Amsterdam: Elsevier Science BV.
48. Samson WK, Resh ZT, Murphy TC. 2000. A novel action of the newly described prolactin-releasing peptides. Brain Res 858:19-25.
49. Santama N, Benjamin PR. 2000. Gene expression and function of FMRFamide-related neuropeptides in the snail Lymnaea. Microsc Res Techniq 49:547-556.
50. Saper C. 1990. Hypothalamus. In: Paxinos G, editor. The human nervous system. Sydney: Academic Press. p 389-413.
51. Sawchenko PE, Swanson LW. 1983. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 218:121-144.
52. Seal LJ, Small CJ, Kim MS, Stanley SA, Taheri S, Ghatei MA, Bloom SR. 2000. Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology 141:1909-1912.
53. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck Jr PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532.
54. Sundblom DM, Hyrkko A, Fyhrquist F. 1998. Pulsative secretion of neuropeptide FF into human blood. Peptides 19:1165-1170.
55. Sunter D, Hewson AK, Lynam S, Dickson SL. 2001. Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci Lett 313:145-148.
56. Swanson LW, Sawchenko PE. 1983. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269-324.
57. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P, Ziff E. 1999. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55:804-811.
58. Yang HY, Martin RM. 1995. Isolation and characterization of neuropeptide FF-like peptide from brain and spinal cord of rat. Soc Neurosci Abstr 21:760.
59. Yang HY, Fratta W, Majane EA, Costa E. 1985. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82:7757-7761.
60. Yokoi H, Arima H, Kondo K, Murase T, Iwasaki Y, Yang HY, Oiso Y. 1998. Antiserum against neuropeptide FF augments vasopressin release in conscious rats. Peptides 19:393-395.
61. Zajac JM, Gouarderes C. 2000. Neuropeptide FF receptors. In: Quirion R, Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy, vol 16. Amsterdam: Elsevier. p 163-193.
62. Zeng Z, McDonald TP, Wang R, Liu Q, Austin CP. 2002. Studies on the expression of NPFF2 receptor in the spinal cord and brain stem of African green monkey by immunohistochemistry and autoradiography. Program No. 258.7.2002, Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.